Masanori Sugimoto - Concepedia

Author

Masanori Sugimoto

Taisho Pharmaceutical (Japan)

Also Known As

Masanori Sugimoto, Yuki Hashimoto

Publications

836

Citations

H-Index

Concepts

All Affiliations

Taisho Pharmaceutical (Japan)The University of Osaka Okayama University Keio University

About

Masanori Sugimoto is an author at Taisho Pharmaceutical (Japan) specializing in medicine, pharmacology, and dermatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	537
2	Engineering	3	3	95
3	Natural Sciences	3	3	69
4	Health Sciences	2	2	42
5	Allergy	2	2	50

Masanori Sugimoto

Publications

808

Citations

H-Index

Page 1

	Year	Citations
Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis Akiko Takaoka, Iwao Arai, Masanori Sugimoto, European Journal of Pharmacology InflammationImmunogeneticsIl-31 Gene TranscriptsAtopic DermatitisImmune Cell Development	2005	121
Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis Iwao Arai, Norikazu Takano, Yuki Hashimoto, European Journal of Pharmacology InflammationAtopic DermatitisImmunologySkin AllergyNc/nga Mice	2004	59
Total synthesis of callystatin A, a potent cytotoxic polyketide from the marine sponge, Callyspongia truncata Nobutoshi Murakami, Wang Wei-qi, Masashi Aoki, Tetrahedron Letters Marine BiotechnologyEngineeringCallystatin ATotal SynthesisMarine Sponge	1998	54
Absolute stereostructure and total synthesis of leptomycin B Motomasa Kobayashi, Weiqi Wang, Yasuhiro Tsutsui, Tetrahedron Letters Peptide SynthesisStereoselective SynthesisBiochemistryTotal Synthesis	1998	51
Modulation of scratching behavior by silencing an endogenous cyclooxygenase‐1 gene in the skin through the administration of siRNA Tomoyuki Inoue, Masanori Sugimoto, Takanobu Sakurai, The Journal of Gene Medicine	2007	46
Prostaglandin D2 and prostaglandin E2 accelerate the recovery of cutaneous barrier disruption induced by mechanical scratching in mice Yusuke Honma, Iwao Arai, Yuki Hashimoto, European Journal of Pharmacology Prostaglandin D2MedicineCutaneous BiologyCutaneous Barrier DisruptionCytoskeleton	2005	45
Participation of the β-hydroxyketone part for potent cytotoxicity of callystatin A, a spongean polyketide Nobutoshi Murakami, Masanori Sugimoto, Motomasa Kobayashi Bioorganic & Medicinal Chemistry β-Hydroxyketone PartCallystatin ASpongean PolyketideMedicinePolymer-drug Conjugate	2001	34
New Semisynthetic Quassinoids with in Vivo Antimalarial Activity Nobutoshi Murakami, Masanori Sugimoto, Motoyuki Kawanishi, Journal of Medicinal Chemistry Antiparasitic AgentNew Semisynthetic QuassinoidsToxicological MechanismOxidative StressMedicinal Chemistry	2003	28
Participation of the conjugated diene part for potent cytotoxicity of callystatin A, a spongean polyketide Nobutoshi Murakami, Masanori Sugimoto, Tatsuo Nakajima, Bioorganic & Medicinal Chemistry Callystatin AMedicineSpongean PolyketidePolymer-drug ConjugateAnti-cancer Agent	2000	27
Role of scratch‐induced cutaneous prostaglandin D<sub>2</sub> production on atopic‐like scratching behaviour in mice Akiko Takaoka, Iwao Arai, Masanori Sugimoto, Experimental Dermatology	2007	26

Page 1